Back to Top Skip to main content Skip to sub-navigation

Understanding the potential of COVID-19 convalescent plasma

Image of a researcher scanning a unit of plasma in a lab. Click to open a larger version of the image. U.S. Army Sgt. Reginald Miles labels donated liquid plasma at the Landstuhl Blood Donor Center. Researchers are studying COVID-19 convalescent plasma to harness the power of neutralizing antibodies to help patients. (Photo by Volker Ramspott)

Recommended Content:

Coronavirus | Convalescent Plasma Collection Program | Armed Services Blood Program

The Department of Defense has set a goal to collect more than 8,000 donated units of plasma from patients who have recovered from COVID-19 by Sept. 30, 2020. This blood will be used to treat critically ill patients and support the development of an effective treatment against the disease.

Like a missile locking on its target, antibodies attack invaders inside the body with a singularity of purpose: search and destroy. Typically, infection-fighting white blood cells produce antibodies as an appropriate response to an invading germ. In some people whose immune systems can’t mount a sufficient attack against a virus, donated antibodies from another person’s plasma may help. Researchers believe the power of antibodies lies in their ability to bind to a virus and neutralize it, or block it from entering cells, said Dr. Kayvon Modjarrad, director of the Emerging Infectious Diseases Branch at the Walter Reed Army Institute of Research in Silver Spring, Maryland. Modjarrad leads the Army’s COVID-19 vaccine development research.

But not all antibodies are created the same. “Antibodies come in different flavors, some of them are neutralizing and some of them are non-neutralizing and we don’t know exactly which individuals are developing what type of antibody,” said Shelly Krebs, chief of B Cell Biology Core at WRAIR Military HIV Research program.

COVID-19 convalescent plasma, or CCP, from a recovered patient could be a mixture of both neutralizing and non-neutralizing antibodies. In fact, people infected with COVID-19 can have varying antibody responses. Some may not have enough antibodies in their plasma to benefit another patient, which is why CCP first needs to be tested for neutralizing antibody levels before transfusing, explained Modjarrad. His lab works to understand the mechanism of COVID-19 antibodies to predict the levels required to offer a person protection from the virus.

Transfusing antibodies provides short-term immunity as the donor antibodies last several weeks to months inside the body, said Navy Capt. (Dr.) Todd Gleeson of the Navy Bloodborne Infection Management Center, located at Naval Support Activity Bethesda, Maryland. “It is likely that a person with COVID-19 who receives CCP will also still develop their own immune cells and produce antibodies to fight the virus if that person is re-exposed in the future,” said Gleeson, who leads a convalescent plasma study of patients at Walter Reed National Military Medical Center also at NSAB in Bethesda. But scientists just can’t confirm that yet. They hope to uncover the answer and many more as they study CCP and COVID-19 antibodies to better treat patients and develop future vaccines.

Military medical treatment facilities will soon take part in an observational study across the Department of Defense to help researchers track trends among patients with COVID-19. The data will help trace recovered patients to ask for CCP donations as the DoD seeks to build a storehouse of CCP for patients admitted to Military Health System facilities and those deployed outside the U.S., explained Army Col. (Dr.) Andrew Cap, director of research at the Army Institute of Surgical Research in San Antonio, Texas. “The goal is to build a convalescent plasma capability within the DoD, both on the collection and on the treatment side,” said Cap, who helped draft a CCP protocol for the DoD.

Future research may lead to the development of highly concentrated neutralizing antibodies extracted from large quantities of convalescent plasma as a potential therapy for prevention and treatment, added Cap.

Scientists believe monoclonal antibodies—derived from a single immune cell—may also hold potential as both a treatment and preventive measure against COVID-19. Krebs and her team have engineered monoclonal antibodies in the lab by isolating the best neutralizing antibodies from CCP samples to create an army of exact replicas that target the COVID-19 virus down to the atomic level, explained Modjarrad. “We know where and how well it’s going to target, and we know the kinetics of how long it will last in the body and how long it will provide protection,” he explained, noting convalescent plasma does not provide that level of effectiveness. “CCP is not generally used for prevention but for treatment.” Monoclonal antibodies could be used for both treatment and prevention of COVID-19 because the transfused neutralizing antibodies would provide immediate immunity, he added.

Monoclonal antibodies have been in use for decades and revolutionized cancer treatment. Krebs’ lab plans to expand the research into monoclonal antibodies against COVID-19 into animal studies this summer. “Our primary goal is to come up with a treatment for people who have COVID-19,” she said.

Anyone able to donate convalescent plasma should contact the Armed Services Blood Program or go online to find a complete list of available collection centers.

You also may be interested in...

The 150th Security Forces Squadron supports NM COVID-19 response effort

Article
5/29/2020
Group of military personnel posting for a picture

The 150th Security Forces Squadron and the New Mexico National Guard’s Joint Task Force COVID-19 are providing support that may not otherwise be available to New Mexico communities and their citizens.

Recommended Content:

Coronavirus

DoD launches effort to collect COVID-19 convalescent plasma

Article
5/29/2020
Image of man wearing mask and giving blood

Plasma donations needed in the fight against COVID-19

Recommended Content:

Coronavirus

Building Your Mental Health Through Resiliency

Article
5/29/2020
Soldier walking through a maze

Being able to think about things from a different perspective is critical.

Recommended Content:

Coronavirus

DOD COVID-19 Survivor Gives Shoutout to Doctors, Plasma Donors

Article
5/29/2020
Image of soldier sitting on a bench with flowers and a balloon

Bright was the first person in the District of Columbia to receive convalescent plasma.

Recommended Content:

Coronavirus

DoD experts address COVID-19 effects on mental health

Article
5/29/2020
Image of soldier wearing a mask

As the world adjusts to a new normal, here’s how to keep mentally healthy.

Recommended Content:

Coronavirus | Total Force Fitness

'Home sweet home' leaves a sour taste for some quarantine-weary

Article
5/28/2020
Family playing board game

Mental health professionals offer tips on managing during uncertain times

Recommended Content:

Coronavirus | Psychological Fitness

MHS Minute: Military Leading the Charge on COVID-19 Research

Video
5/28/2020
Image of MHS Minute Carousel

The military continues to serve on the front lines of research and treatment in response to the COVID-19 pandemic. Tune in to the MHS Minute to learn more.

Recommended Content:

Coronavirus

USU Aids Health Care Providers, Community in Pandemic

Article
5/27/2020
Image of two healthcare workers looking sad

USU’s Center for the Study of Traumatic Stress provides fact sheets as a resource for providers and the community.

Recommended Content:

Coronavirus | Public Health

Defending the Homeland: Regional Health Command-Atlantic staff treat COVID-19 patients at NJ hospital

Article
5/27/2020
Three people in scrubs around a patient on a hospital bed

The officers assigned to the program were selected because they have medical specialties typically used in military forward surgical teams.

Recommended Content:

Coronavirus

Force Health Protection Guidance (Supplement 9) -Department of Defense Guidance for Deployment and Redeployment of Individuals and Units during the Novel Coronavirus Disease 2019 Pandemic

Publication
5/26/2020

This memorandum provides force health protection (FHP) deployment and redeployment guidance for Service members (including Reserve Component (RC) and National Guard members in a title 10 or title 32 duty status) and DoD civilian employees deploying within and outside the United States during the COVID-19 pandemic, consistent with references (a) and (b).

Recommended Content:

Coronavirus

Foreign liaison officers bring new perspective to MHS

Article
5/26/2020
Image of three men talking to each other

Medical information exchange aids in better care everywhere

Recommended Content:

Global Health Engagement | Coronavirus

COVID-19: Lifestyle Tips to Stay Healthy

Article
5/22/2020
A collage of four pictures of people exercising, sleeping and eating healthy food. Click to open a larger version of the image.

As we move toward a third year of the COVID-19 pandemic, the virus has changed many of our daily routines in ways no one anticipated and that have become the new normal.

Recommended Content:

Coronavirus | Health Readiness | Total Force Fitness

Using mobile mental health apps to cope during social isolation

Article
5/22/2020
Soldier holding cell phone, showing app to another person

Learn how your smartphone can serve as a lifeline

Recommended Content:

Coronavirus | Public Health | Depression | Connected Health | Total Force Fitness

Medical maintainers play key role in Army’s response to COVID-19

Article
5/22/2020
Soldier looking at medical equipment on shelves

In the field, Soldiers trained as Biomedical Equipment Specialists, or 68As, handle unit-level sustainment of deployed medical devices.

Recommended Content:

Coronavirus

Air Force bioenvironmental engineers expand mission in aerovac, workspaces

Article
5/21/2020
Military Captain and team cleaning large, plastic enclosed space

The aeromedical evacuation mission became a top priority as COVID-19 began to spread.

Recommended Content:

Coronavirus | Public Health
<< < ... 26 27 28 29 30  ... > >> 
Showing results 406 - 420 Page 28 of 38

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.